A significant breakthrough in cancer research is occurring with the use of VHH fragments to re-engage dysfunctional p53. This essential malignant protector protein is frequently disabled in several types of cancer, https://bookmarkspedia.com/story7693953/mini-antibodies-reactivate-tumor-suppressor-p53-new-potential-pathway-for-malignant-treatment